questionsmedicales.fr
Maladies du système immunitaire
Hypersensibilité
Hypersensibilité retardée
Hypersensibilité retardée : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Hypersensibilité retardée
Tests cutanés
Tests de patch
Lymphocytes T
Éruption cutanée
Réaction allergique
Analyse sanguine
Inflammation
Antécédents médicaux
Allergènes
Symptômes
5
Éruption cutanée
Démangeaisons
Réaction retardée
Allergène
Symptômes systémiques
Fatigue
Réaction cutanée
Vésicules
Variabilité des symptômes
Réaction individuelle
Prévention
5
Tests d'allergie
Prévention des réactions
Changements de mode de vie
Allergènes alimentaires
Antihistaminiques
Prévention
Gestion des allergies
Médicaments d'urgence
Traitements
5
Corticostéroïdes
Évitement des allergènes
Antihistaminiques
Démangeaisons
Corticostéroïdes
Inflammation
Traitements topiques
Pommades corticostéroïdes
Traitement pédiatrique
Hypersensibilité
Complications
5
Infections cutanées
Complications
Maladies chroniques
Réactions répétées
Anaphylaxie
Réactions sévères
Qualité de vie
Démangeaisons
Hospitalisation
Traitement intensif
Facteurs de risque
5
Facteurs de risque
Antécédents d'allergies
Professions à risque
Produits chimiques
Antécédents familiaux
Allergies
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hypersensibilité retardée : Questions médicales les plus fréquentes",
"headline": "Hypersensibilité retardée : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hypersensibilité retardée : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hypersensibilité retardée"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hypersensibilité",
"url": "https://questionsmedicales.fr/mesh/D006967",
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité",
"code": {
"@type": "MedicalCode",
"code": "D006967",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Eczéma de contact allergique",
"alternateName": "Dermatitis, Allergic Contact",
"url": "https://questionsmedicales.fr/mesh/D017449",
"about": {
"@type": "MedicalCondition",
"name": "Eczéma de contact allergique",
"code": {
"@type": "MedicalCode",
"code": "D017449",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dermatite photoallergique",
"alternateName": "Dermatitis, Photoallergic",
"url": "https://questionsmedicales.fr/mesh/D017454",
"about": {
"@type": "MedicalCondition",
"name": "Dermatite photoallergique",
"code": {
"@type": "MedicalCode",
"code": "D017454",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dermatite de contact au Rhus toxicodendron",
"alternateName": "Dermatitis, Toxicodendron",
"url": "https://questionsmedicales.fr/mesh/D011040",
"about": {
"@type": "MedicalCondition",
"name": "Dermatite de contact au Rhus toxicodendron",
"code": {
"@type": "MedicalCode",
"code": "D011040",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.150.700"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose",
"alternateName": "Sarcoidosis",
"url": "https://questionsmedicales.fr/mesh/D012507",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose",
"code": {
"@type": "MedicalCode",
"code": "D012507",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sarcoïdose pulmonaire",
"alternateName": "Sarcoidosis, Pulmonary",
"url": "https://questionsmedicales.fr/mesh/D017565",
"about": {
"@type": "MedicalCondition",
"name": "Sarcoïdose pulmonaire",
"code": {
"@type": "MedicalCode",
"code": "D017565",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Uvéoparotidite",
"alternateName": "Uveoparotid Fever",
"url": "https://questionsmedicales.fr/mesh/D014608",
"about": {
"@type": "MedicalCondition",
"name": "Uvéoparotidite",
"code": {
"@type": "MedicalCode",
"code": "D014608",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C20.543.418.575.865"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hypersensibilité retardée",
"alternateName": "Hypersensitivity, Delayed",
"code": {
"@type": "MedicalCode",
"code": "D006968",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Elizabeth J Phillips",
"url": "https://questionsmedicales.fr/author/Elizabeth%20J%20Phillips",
"affiliation": {
"@type": "Organization",
"name": "Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Elizabeth.j.phillips@vumc.org."
}
},
{
"@type": "Person",
"name": "Shuen-Iu Hung",
"url": "https://questionsmedicales.fr/author/Shuen-Iu%20Hung",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan. Electronic address: sihung@cgmh.org.tw."
}
},
{
"@type": "Person",
"name": "Andrew Gibson",
"url": "https://questionsmedicales.fr/author/Andrew%20Gibson",
"affiliation": {
"@type": "Organization",
"name": "Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia."
}
},
{
"@type": "Person",
"name": "Chuang-Wei Wang",
"url": "https://questionsmedicales.fr/author/Chuang-Wei%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Wen-Hung Chung",
"url": "https://questionsmedicales.fr/author/Wen-Hung%20Chung",
"affiliation": {
"@type": "Organization",
"name": "Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung Branch, No. 222, Maijin Rd., Anle Dist., Keelung 204, Taiwan; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan 333, Taiwan. Electronic address: chung1@cgmh.org.tw."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain Metastases.",
"datePublished": "2022-07-20",
"url": "https://questionsmedicales.fr/article/35877265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/curroncol29070405"
}
},
{
"@type": "ScholarlyArticle",
"name": "Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.",
"datePublished": "2023-01-11",
"url": "https://questionsmedicales.fr/article/36631883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jon.13080"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy and safety of prophylaxis for venous thromboembolism in brain neoplasm patients undergoing neurosurgery: a systematic review and Bayesian network meta-analysis.",
"datePublished": "2023-02-10",
"url": "https://questionsmedicales.fr/article/36763224",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11239-023-02780-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Decreasing rates of colectomy for benign neoplasms: A nationwide analysis.",
"datePublished": "2023-10-25",
"url": "https://questionsmedicales.fr/article/37878628",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0293389"
}
},
{
"@type": "ScholarlyArticle",
"name": "Tumefactive demyelinating lesions versus CNS neoplasms, a comparative study.",
"datePublished": "2023-09-03",
"url": "https://questionsmedicales.fr/article/37717306",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.msard.2023.104992"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007154"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hypersensibilité",
"item": "https://questionsmedicales.fr/mesh/D006967"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hypersensibilité retardée",
"item": "https://questionsmedicales.fr/mesh/D006968"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hypersensibilité retardée - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hypersensibilité retardée",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hypersensibilité retardée",
"description": "Comment diagnostiquer l'hypersensibilité retardée ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes indiquent une hypersensibilité retardée ?\nPeut-on diagnostiquer par des analyses sanguines ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Brain+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hypersensibilité retardée",
"description": "Quels sont les symptômes courants ?\nLes symptômes apparaissent-ils immédiatement ?\nY a-t-il des symptômes systémiques ?\nComment se manifeste une réaction cutanée ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Brain+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hypersensibilité retardée",
"description": "Comment prévenir l'hypersensibilité retardée ?\nLes tests d'allergie aident-ils à la prévention ?\nLes changements de mode de vie sont-ils nécessaires ?\nLes médicaments préventifs sont-ils disponibles ?\nComment gérer les expositions accidentelles ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Brain+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hypersensibilité retardée",
"description": "Quel est le traitement principal de l'hypersensibilité retardée ?\nLes antihistaminiques sont-ils efficaces ?\nComment les corticostéroïdes aident-ils ?\nY a-t-il des traitements topiques recommandés ?\nLes traitements sont-ils différents pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Brain+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hypersensibilité retardée",
"description": "Quelles complications peuvent survenir ?\nL'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?\nY a-t-il un risque d'anaphylaxie ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications nécessitent-elles une hospitalisation ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Brain+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hypersensibilité retardée",
"description": "Quels sont les facteurs de risque principaux ?\nL'âge influence-t-il le risque d'hypersensibilité ?\nLes professions exposées sont-elles à risque ?\nLe stress peut-il aggraver l'hypersensibilité ?\nLes antécédents familiaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D006968?mesh_terms=Brain+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer l'hypersensibilité retardée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical et des tests cutanés spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de patch et les tests de stimulation lymphocytaire sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une hypersensibilité retardée ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées, démangeaisons et rougeurs apparaissent après exposition à l'allergène."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer par des analyses sanguines ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les analyses sanguines ne sont pas spécifiques, mais peuvent aider à évaluer l'inflammation."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les allergènes potentiels et les antécédents d'exposition."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent éruptions cutanées, démangeaisons, et parfois fièvre."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils immédiatement ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils apparaissent généralement 24 à 72 heures après l'exposition à l'allergène."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre ou la fatigue peuvent survenir dans certains cas."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une réaction cutanée ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "La réaction cutanée se manifeste par des rougeurs, des vésicules et un gonflement localisé."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'hypersensibilité retardée ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition aux allergènes connus est la meilleure méthode de prévention."
}
},
{
"@type": "Question",
"name": "Les tests d'allergie aident-ils à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests d'allergie peuvent identifier les allergènes à éviter pour prévenir les réactions."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils nécessaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des changements de mode de vie, comme éviter certains aliments ou produits, peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Les médicaments préventifs sont-ils disponibles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antihistaminiques peuvent être pris en prévention avant une exposition connue."
}
},
{
"@type": "Question",
"name": "Comment gérer les expositions accidentelles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Avoir un plan d'action et des médicaments d'urgence peut aider à gérer les expositions accidentelles."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal de l'hypersensibilité retardée ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal consiste en l'évitement de l'allergène et l'utilisation de corticostéroïdes."
}
},
{
"@type": "Question",
"name": "Les antihistaminiques sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antihistaminiques peuvent soulager les démangeaisons, mais ne traitent pas la cause."
}
},
{
"@type": "Question",
"name": "Comment les corticostéroïdes aident-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes réduisent l'inflammation et soulagent les symptômes cutanés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements topiques recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crèmes ou pommades corticostéroïdes peuvent être appliquées sur les zones affectées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents pour les enfants ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des infections cutanées peuvent survenir si les lésions sont grattées."
}
},
{
"@type": "Question",
"name": "L'hypersensibilité retardée peut-elle entraîner des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions répétées peuvent contribuer à des maladies cutanées chroniques."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque d'anaphylaxie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anaphylaxie est rare dans l'hypersensibilité retardée, mais des réactions sévères peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent entraîner des douleurs, des démangeaisons et une gêne sociale."
}
},
{
"@type": "Question",
"name": "Les complications nécessitent-elles une hospitalisation ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, une hospitalisation peut être nécessaire pour un traitement intensif."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque principaux ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents d'allergies, l'exposition répétée et la génétique sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'hypersensibilité ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées peuvent être plus à risque."
}
},
{
"@type": "Question",
"name": "Les professions exposées sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines professions, comme celles en contact avec des produits chimiques, présentent un risque accru."
}
},
{
"@type": "Question",
"name": "Le stress peut-il aggraver l'hypersensibilité ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et augmenter la sensibilité aux allergènes."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un historique familial d'allergies peut augmenter le risque d'hypersensibilité retardée."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Elizabeth.j.phillips@vumc.org.
Publications dans "Hypersensibilité retardée" :
3 publications dans cette catégorie
Affiliations :
Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department and Institute of Pharmacology, National Yang Ming Chiao Tung University, No.155, Sec.2, Linong Street, Taipei, 112 Taiwan. Electronic address: sihung@cgmh.org.tw.
Publications dans "Hypersensibilité retardée" :
3 publications dans cette catégorie
Affiliations :
Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
Clinical Immunology and Allergy, McGill University Health Center, Montréal, Canada.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Cancer Vaccine & Immune Cell Therapy Core Lab, Department of Medical Research, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Drug Hypersensitivity Clinical and Research Center, Chang Gung Memorial Hospital, Linkou Branch, No. 5, Fuxing St., Guishan Dist., Taoyuan 333, Taiwan; Department of Dermatology, Xiamen Chang Gung Hospital, No. 123, Xiafei Road, Haicang District, Xiamen, China; Whole-Genome Research Core Laboratory of Human Diseases, Chang Gung Memorial Hospital, Keelung Branch, No. 222, Maijin Rd., Anle Dist., Keelung 204, Taiwan; College of Medicine, Chang Gung University, No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan 333, Taiwan. Electronic address: chung1@cgmh.org.tw.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
IRCCS Oasi Maria S.S., Troina, Italy.
Fondazione Mediterranea G.B. Morgagni, Italy.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
département de Dermatologie et Allergologie, Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, AP-HP.Sorbonne Université, Hôpital Tenon, Paris F75020, France. Electronic address: annick.barbaud@aphp.fr.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Faculty of Health Sciences, Universidad Europea de Valencia, 46010 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Faculty of Health Sciences, Universidad Europea de Valencia, 46010 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Pharmacy Unit, University General Hospital Consortium, 46014 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Biomedical Research Networking Centre on Respiratory Diseases (CIBERES), Health Institute Carlos III, 28029 Madrid, Spain.
Department of Pharmacology, Faculty of Medicine, University of Valencia, 46010 Valencia, Spain.
Research and Teaching Unit, University General Hospital Consortium, 46014 Valencia, Spain.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Immunology and Infectious Diseases, Murdoch University, Murdoch, WA, Australia.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Austin Health, Center for Antibiotic Allergy and Research, Heidelberg, VIC, Australia.
Department of Oncology, Sir Peter MacCallum Cancer Center, The University of Melbourne, Parkville, VIC, Australia.
Department of Medicine (Austin Health), The University of Melbourne, Heidelberg, VIC, Australia.
The National Center for Infections in Cancer, Peter MacCallum Cancer Center, Melbourne, VIC, Australia.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Allergy, Zhongnan Hospital of Wuhan University, Wuhan, China.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Jagiellonian University Medical College, 18 Czysta St., 31-121 Krakow, Poland.
Department of Immunology, Hospital de la Princesa, Health Research Institute of Princesa Hospital (ISS-IP), Autonomous University of Madrid, 28006 Madrid, Spain.
Section of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT 208011, USA.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Jagiellonian University Medical College, 18 Czysta St., 31-121 Krakow, Poland.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Section of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT 208011, USA.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Immunology, Jagiellonian University Medical College, 18 Czysta St., 31-121 Krakow, Poland.
Section of Rheumatology, Allergy and Clinical Immunology, Yale University School of Medicine, New Haven, CT 208011, USA.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Werner Siemens Imaging Center, Department of Preclinical Imaging and RadiopharmacyEberhard Karls University, 72076 Tübingen, Germany.
Publications dans "Hypersensibilité retardée" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Eberhard Karls University, 72076 Tübingen, Germany.
Publications dans "Hypersensibilité retardée" :
Brain metastases (BMs) in patients with extra-pulmonary neuroendocrine neoplasms (EP-NENs) are rare, and limited clinical information is available. The aim of this study was to detail the clinicopatho...
A retrospective single-centre analysis of consecutive patients with EP-NENs (August 2004-February 2020) was conducted. Median overall survival (OS)/survival from BMs diagnosis was estimated (Kaplan-Me...
Of 730 patients, 17 (1.9%) had BMs, median age 61 years (range 15-77); 8 (53%) male, unknown primary NEN site: 40%. Patients with BMs had grade 3 (G3) EP-NENs 11 (73%), G2: 3 (20%), G1: 1 (7%). Eight ...
BMs in patients with EP-NENs are rare and of increased risk in G3 vs. G1 + G2 EP-NENs. Survival outcomes are poor, and a greater understanding is needed to improve therapeutic outcomes....
Postradiation treatment necrosis is one of the most serious late sequelae and appears within 6 months. The magnetic resonance spectroscopy imaging (MRSI) has been used for the detection of brain tumor...
The research was performed in accordance with the preferred reporting items for systematic review and meta-analysis guidelines. International electronic databases including 15 English sources were inv...
Nine studies were enrolled in the meta-analysis with a total of 354 patients (203 male and 151 female) whose average age ranged from 4 to 74 years. Anbarloui et al., Elias et al., Nemattalla et al., S...
MR spectroscopy is effective in distinguishing recurrent brain tumors from necrosis. Our meta-analysis revealed that Cho/NAA, Cho/Cr, and NAA/Cr ratios were significantly better predictor of detected ...
Neurosurgeons often face this dilemma. Brain neoplasm patients undergoing neurosurgery are at a high risk of venous thrombosis. However, antithrombotic drugs may induce bleeding complications. Therefo...
Despite advances in endoscopic techniques for management of benign colonic neoplasms, a rise in rates of surgical treatment has been reported. We used a nationally representative cohort to characteriz...
All patients undergoing elective partial colectomy for benign or malignant colonic neoplasms were identified using the 2012-2019 National Inpatient Sample. Those presenting with inflammatory bowel dis...
Of 569,280 colectomy procedures included for analysis, 153,435 (27.0%) were performed for benign lesions. The proportion of Benign operations decreased from 28.6% in 2012 to 23.7% in 2019 (P for trend...
The present national study identifies a decrease in colectomy for benign polyps from 2012-2019. Future investigations should identify patients who would most benefit from surgical resection and addres...
Differentiating tumefactive demyelinating lesions (TDL) from neoplasms of the central nervous system continues to be a diagnostic dilemma in many cases....
Our study aimed to examine and contrast the clinical and radiological characteristics of TDL, high-grade gliomas (HGG) and primary CNS lymphoma (CNSL)....
This was a retrospective review of 66 patients (23 TDL, 31 HGG and 12 CNSL). Clinical and laboratory data were obtained. MRI brain at presentation were analyzed by two independent, blinded neuroradiol...
Patients with TDLs were younger and predominantly female. Sensorimotor deficits and ataxia were more common amongst TDL whereas headaches and altered mental status were associated with HGG and CNSL. C...
Careful evaluation of clinical and radiological features helps in differentiating TDLs at first presentation from CNS neoplasms....
The aim of the study was to investigate the concentration and activity of tissue factor (TF) and Tissue factor pathway inhibitor (TFPI) as well as the concentration of thrombin-antithrombin (TAT) comp...
Pediatric benign laryngeal tumors can often be treated as same-day surgeries. This study identified factors associated with prolonged hospital stay in children undergoing laryngeal surgery for benign ...
A retrospective analysis of records of pediatric patients who underwent laryngeal surgery with a post-op diagnosis of benign tumor was performed with the American College of Surgeons Pediatric Nationa...
1775 patients were identified with a mean age at time of surgery of 8.95 years (95% CI 8.76-9.14). 966 (54.4%) were males and 809 (45.6%) were females. Mean LOS was 0.22 days (95% CI 0.12-0.32). Only ...
This study suggests that laryngeal surgery for benign tumors is safe but recognizes that patients with comorbidities or young children may require a prolonged stay. Awareness of these implications may...
Preoperative anxiety is common among patients, particularly in neurosurgical patients. The aim of the study was to evaluate the incidence and predictive factors of preoperative anxiety using the state...
Sixty patients aged 18 to 65 years with American Society of Anesthesiologists physical status score I/II scheduled for elective craniotomy for a supratentorial neoplasm were recruited into this prospe...
Sixty percent of patients had preoperative anxiety (STAI-S ≥37). An APAIS score of 10 identified preoperative anxiety with a sensitivity, specificity, and positive predictive value of 97%, 96%, and 97...
Patients with supratentorial neoplasms have a high incidence of preoperative anxiety; an APAIS score of 10 is the optimal cutoff to identify anxious patients in the preoperative period. Need-for-infor...
During the V Siena Immuno-Oncology (IO) Think Tank meeting in 2021, conditions were discussed which favor immunotherapy responses in either primary or secondary brain malignancies. Core elements of th...
Gliomas are malignant tumors in the central nervous system. Cuproptosis is a newly discovered cell death mechanism targeting lipoylated tricarboxylic acid cycle proteins. Previous studies have found t...